MedTrace Logo

Gabapentin Premedication for ACL Reconstruction: RCT

NCT03417479 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2021-12-08

No results posted yet for this study

Summary

This double blind randomized control trial will enroll 100 participants ages 12-18 years, undergoing ACL repair. Participants receive gabapentin or placebo preoperatively. Outcome measurements of self-reported pain score using scale of 1 to 10 with 10 being the worse obtained from the EMR and participants interviews with a phone nurse for five days postoperatively to determine severity of pain as well as use of opioids.

Conditions

  • Anterior Cruciate Ligament (ACL) Reconstruction

Interventions

OTHER

Gabapentin

Sponsors & Collaborators

  • Children's Healthcare of Atlanta

    lead OTHER

Principal Investigators

  • Margaret A Gettis, DNP · Children's Healthcare of Atlanta

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-09
Primary Completion
2018-10-23
Completion
2018-10-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03417479 on ClinicalTrials.gov